Quality assurance is a key element in the process of creating safe and effective preparations. Furthermore, the implementation of quality-assurance measures allows 503A pharmacies to ensure accurate, well-made preparations to their customers. When corrective and preventive measures are not implemented, the risk of errors is increased, like subtherapeutic or supratherapeutic compounded medications. The objective of this article was to demonstrate the importance of quality assurance through the development and validation of the compounding method, preparation characterization, training, implementation of a master formulation record, compounding protocol, and verification to prevent compounding errors. Two groups, comprising of 10 students, compounded lidocaine gel following the quality-assurance guidelines in accordance with United States Pharmacopeia Chapter . Following the trial, the preparations from both groups were tested to evaluate the content of lidocaine using high-performance liquid chromatography and an ultra-viscosity detector. The study results indicated that the newly developed, validated procedure produced a stable, uniform, highly reproducible (%Assay ± SD; 101.65% ± 1.04), and elegant (clear hydro-alcoholic gel) preparation with a high yield (~98.5%). There was no significant difference observed in the %Assay results obtained from the two groups (%Assay ±SD; P1 98.76% ±1.01, and P2 99.02% ±1.39, %Difference 0.3). Overall, our findings suggest that the implementation of quality assurance could significantly reduce compounding errors and improve both preparation quality and patient safety.Risk, which can come from various sources, is the exposure to loss or injury. Included, but not limited to common risks associated by business owners, are natural disasters, accidents, legal liabilities, weather-related events, and criminal activities. Specific to pharmacy is professional liability risk, including physical harm to a patient. This article provides an understanding of some of the risks faced by business owners and pharmacists, transferal of risk to another entity such as an insurance company, and an understanding of the insurance policy itself.Following a 240% increase in the number of compounded sterile preparations between 2012 and 2013, three pharmacy technicians at a metropolitan public hospital suffered hand-related, repetitive strain injuries. This study describes the main safety measures implemented to reduce the risk of repetitive strain injuries associated with sterile compounding at the study hospital, and reports pharmacy technicians' perceptions of their effectiveness. The implemented risk reduction strategies were categorized into five domains of 1) equipment and consumables, 2) training and assessment, 3) Lean waste reduction, 4) roster and shift limits, and 5) workload allocation score. Pharmacy technicians' feedback was collected through an anonymous survey in 2020, five years after the implementation of all safety measures. Responders rated their perceived effectiveness of each strategy domain using a five-point Likert Scale, ranging from very ineffective to very effective. All pharmacy technicians who had been undertaking aseptic compounding activities for at least one year between 2015 and 2020 were invited to take the survey. The five domains of 1) equipment and consumables, 2) training and assessment, 3) Lean waste reduction, 4) roster and shift limits, and 5) workload allocation score were rated effective or very effective by 86%, 67%, 86%, 57%, and 71% of pharmacy technicians, respectively (n=7). The overall effectiveness of all interventions combined was rated effective or very effective by 72% of the participants. Pharmacy technicians' feedback indicates the majority perceive the implemented strategies effective in reducing the risk of repetitive strain injuries associated with aseptic compounding. Short stature in children is a common reason for referral to pediatric endocrinologists. The underlying cause of short stature remains unclear in many cases and patients often receive unsatisfactory, descriptive diagnoses. While textbooks underline the rarity of genetic causes of growth hormone (GH) insensitivity and the severity of its associated growth failure, increased genetic testing in patients with short stature of unclear origin has revealed gene defects in the GH/insulin-like growth factor (IGF-I) axis associated with milder phenotypes. As such, heterozygous IGF1 gene defects have been reported as a cause of mild and severe short stature. Here, we aimed to describe the clinical and hormonal profile of children with IGF1 haploinsufficiency and their short-term response to growth hormone treatment (GHT). We describe five patients presenting with short stature, microcephaly, and in four out of five born small for gestational age diagnosed with IGF1 haploinsufficiency. The phenotype of these patients resembles that of previously described cases with similar gene defects. In our series, segregation of the short stature with the IGF1 deletion is evident from the pedigrees and our data suggests a modest response to GHT. This study is the first case series of complete heterozygous IGF1 deletions in children. The specific genetic defects provide a clear image of the phenotype of IGF1 haploinsufficiency - unbiased by heterozygous mutations with possible dominant negative effects on IGF-I function. We increase the evidence for IGF1 haploinsufficiency as a cause of short stature, microcephaly, and SGA. This study is the first case series of complete heterozygous IGF1 deletions in children. The specific genetic defects provide a clear image of the phenotype of IGF1 haploinsufficiency - unbiased by heterozygous mutations with possible dominant negative effects on IGF-I function. We increase the evidence for IGF1 haploinsufficiency as a cause of short stature, microcephaly, and SGA.Cryptococcus exposure in certain global regions is common and yet virulence in the immunocompetent host remains rare. Radiological findings of pulmonary cryptococcosis may include nonspecific lung nodules or masses indistinguishable from lung cancer or pulmonary tuberculosis. We present a case of an immunocompetent diabetic female who presented with progressively worsening pleuritic chest pain and cough with travel between Tibet and New York 2 months earlier. Chest imaging demonstrated a large lobulated mass, acid-fast bacillus smears were negative, and our patient underwent pulmonary biopsy, which grew rare budding yeast later confirmed by mucicarmine staining as Cryptococcus. Our patient was successfully treated with fluconazole therapy. https://www.selleckchem.com/products/pik-iii.html We hypothesize that the high altitude of Tibet may allow for clinical latency followed by symptomatic reactivation on descent. A raised index of suspicion for pulmonary cryptococcosis with careful attention to travel history is expected to facilitate timely diagnosis.